Publications by authors named "Max Madu"

Claim this Profile
A
Author Correction: Reversal of pre-existing NGFR-driven tumor and immune therapy resistance.
Julia Boshuizen, David W Vredevoogd, Oscar Krijgsman, Maarten A Ligtenberg, Stephanie Blankenstein, Max F Madu

Nat Commun· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Near-Infrared Fluorescence with Indocyanine Green to Assess Bone Perfusion: A Systematic Review.
Marlies Michi, Max Madu, Henri A H Winters, Daniel M de Bruin, Joost R van der Vorst

Life (Basel)· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges in sentinel node pathology in the era of adjuvant treatment.
Viola Franke, Max F Madu, Carolien Bierman, Willem M C Klop, Winan J van Houdt

J Surg Oncol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reversal of pre-existing NGFR-driven tumor and immune therapy resistance.
Julia Boshuizen, David W Vredevoogd, Oscar Krijgsman, Maarten A Ligtenberg, Stephanie Blankenstein, Max F Madu

Nat Commun· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
External validation of the American Joint Committee on Cancer 8th edition melanoma staging system: who needs adjuvant treatment?
Max F Madu, Viola Franke, Bart A Van de Wiel, Willem M C Klop, Katarzyna Jóźwiak

Melanoma Res· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Parotidectomy in patients with head and neck cutaneous melanoma with cervical lymph node involvement.
Danique M S Berger, Martinus M van Veen, Max F Madu, Alexander C J van Akkooi, Wouter V Vogel

Head Neck· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to: Letter re: Efficacy of isolated limb perfusion (ILP) in patients with Merkel cell carcinoma: A multicenter experience.
Linde M van Veenendaal, Max F Madu, Margot E T Tesselaar, Cornelis Kees Verhoef, Dirk J Grünhagen

Eur J Surg Oncol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immediate completion lymph node dissection in stage IIIA melanoma does not provide significant additional staging information beyond EORTC SN tumour burden criteria.
Max F Madu, Viola Franke, Maarten M Bruin, Danique M S Berger, Carolien Bierman

Eur J Cancer· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical prognostic markers in stage IIIC melanoma.
Max F Madu, Jaap H H Schopman, Danique M S Berger, Willem M C Klop, Katarzyna Jóźwiak

J Surg Oncol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isolated Limb Perfusion for Melanoma is Safe and Effective in Elderly Patients.
Max F Madu, Marion M Deken, Jos A van der Hage, Katarzyna Jóźwiak, Michel W J M Wouters

Ann Surg Oncol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PET/CT surveillance detects asymptomatic recurrences in stage IIIB and IIIC melanoma patients: a prospective cohort study.
Max F Madu, Pieter Timmerman, Michel W J M Wouters, Bernies van der Hiel, Jos A van der Hage

Melanoma Res· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Prognostic Markers in Stage IIIB Melanoma.
Max F Madu, Michel W J M Wouters, W Martin C Klop, Bernies van der Hiel, Bart A van de Wiel

Ann Surg Oncol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blue dye can be safely omitted in most sentinel node procedures for melanoma.
Iris M C van der Ploeg, Max F Madu, Jos A van der Hage, Michel W J M Wouters, W Martin C Klop

Melanoma Res· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapamycin induces heme oxygenase-1 in liver but inhibits bile flow recovery after ischemia.
Alwine Kist, Joris Wakkie, Max Madu, Ruth Versteeg, Judith ten Berge

J Surg Res· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis